Completed Cancer Infection & Immunity
Development ofTherapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by MRC.
View the original record at the funder ↗
Researchers
Paresh Vyas (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
In vivo analysis of the interactions between acute myeloid leukaemia, T cells and haematopoietic stem cells to inform the design of immunotherapy protocols
Evaluation of the Efficacy and Safety of LILRB3-Targeted Immunotherapies in Preclinical Models of Human AML
Modelling TEL-AML1 Childhood Acute Lymphoblastic Leukaemia using Human Pluripotent Stem Cells.
Development of a novel therapeutic antibody
Development of anti-CD45 based conditioning agents for haematological malignancies, stem cell transplant and gene therapy
Original classification
Research GrantPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know